Mercado Europeu de Gestão de Doenças Crónicas – Tendências da Indústria e Previsão para 2028

Personalize o seu relatório Personalize o seu relatório Comprar agora Comprar agora Relatório de amostra grátis Relatório de amostra grátis
Casa Healthcare Europe Chronic Disease Management Market
Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Mercado Europeu de Gestão de Doenças Crónicas – Tendências da Indústria e Previsão para 2028

  • Healthcare
  • Publish Reports
  • Jun 2021
  • Europe
  • 350 Páginas
  • Número de tabelas: 109
  • Número de figuras: 45
Comprar agora Comprar agora

>Mercado europeu de gestão de doenças crónicas, por tipo (solução e serviços), tipo de solução (solução local, solução baseada na cloud, baseada na Web), tipo de serviço (serviço educativo, serviço de implementação, serviço de consultoria e outros) , indicação de doença ( Doenças Cardiovasculares (DCV), Diabetes, Doenças Pulmonares Obstrutivas Crónicas (DPOC), Artrite, Asma, Cancro e Outros), Utilizador Final (Prestadores de Cuidados de Saúde, Pagadores de Cuidados de Saúde, Outros), País (Reino Unido, Alemanha , França, Espanha, Itália, Países Baixos , Suíça, Rússia, Bélgica, Turquia, Irlanda, Resto da Europa) Tendências da indústria e previsões para 2028

Mercado Europeu de Gestão de Doenças Crónicas

Análise de Mercado e Insights : Mercado Europeu de Gestão de Doenças Crónicas

Espera-se que o mercado de gestão de doenças crónicas ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 13,7% no período de previsão de 2021 a 2028 e prevê-se que atinja os 591,09 milhões de USD até 2028. Prevê-se que a crescente prevalência de doenças crónicas atue como um motor para o mercado de gestão de doenças crónicas.

A gestão de doenças crónicas (MDL) consiste em cuidados e apoio contínuos para ajudar os indivíduos afectados por uma condição de saúde crónica com os cuidados médicos, conhecimentos, competências e recursos de que necessitam para uma melhor gestão no dia-a-dia. É fornecido principalmente por vários softwares e serviços. A gestão de doenças crónicas ajuda a reduzir os custos dos cuidados de saúde e a melhorar a qualidade de vida dos indivíduos com condições crónicas, prevenindo ou minimizando os efeitos da doença através de cuidados integrados.

Espera-se que o aumento da população geriátrica impulsione o mercado da gestão de doenças crónicas. Espera-se que a falta de acessibilidade restrinja o mercado da gestão de doenças crónicas. Espera-se que o aumento dos novos avanços tecnológicos crie uma oportunidade para o mercado da gestão de doenças crónicas. Prevê-se que a falta de acessibilidade represente um desafio para o mercado da gestão de doenças crónicas.

O relatório de mercado de gestão de doenças crónicas fornece detalhes da quota de mercado, novos desenvolvimentos e análise do pipeline de produtos, impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes, alterações nas regulamentações do mercado, aprovações de produtos, decisões estratégicas, lançamentos de produtos. Para compreender a análise e o cenário do mercado de gestão de doenças crónicas, contacte a Data Bridge Market Research para obter um resumo do analista, a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir o objetivo desejado.

Mercado Europeu de Gestão de Doenças Crónicas

Âmbito do mercado de gestão de doenças crónicas e tamanho do mercado

The chronic disease management market is segmented on the basis of the type, solution type, service type, Disease indication and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the chronic disease management market is segmented into solution and services. In 2021, solution segment is expected to dominate the chronic disease management market due to rising healthcare expenditure.  . 
  • On the basis of solution type, the chronic disease management market is segmented into on-premise solution, cloud-based solution and web-based. In 2021, on-premise solution segment is expected to dominate the chronic disease management market due to development in healthcare infrastructure. .
  • On the basis of service type, the chronic disease management market is segmented into education service, implementation service, consulting service and others. In 2021, implementation services segment is expected to dominate the chronic disease management market due to growing demand for advanced chronic disease management services. 
  • On the basis of Disease indication, the chronic disease management market is segmented into cardiovascular diseases (CVD), diabetes, chronic obstructive pulmonary disorders (COPD), arthritis, asthma, cancer and others. In 2021, cardiovascular diseases (CVD) segment is expected to dominate the chronic disease management market due to rising rate of early diagnosis of cardiovascular diseases (CVD). 
  • On the basis of end user, the chronic disease management market is segmented into healthcare providers, healthcare payers and others. In 2021, healthcare providers segment is expected to dominate the chronic disease management market due to advanced healthcare services provided by the healthcare providers.

Europe Chronic Disease Management Market Country Level Analysis

The disease management market is analyzed and market size information is provided by the country, type, solution type, service type, Disease indication and end user as referenced above.

The countries covered in the Europe chronic disease management market report are the Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Austria, Ireland, and Rest of Europe.

Germany is expected to dominate the Europe chronic disease management market due to the presence of major market players and increased technological advancement in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growing Strategic Activities by Major Market Players to enhance the Awareness for Chronic Disease Management is Boosting the Chronic Disease Management Market

The chronic disease management market also provides you with detailed market analysis for every country growth in chronic disease management market. Additionally, it provides the detail information regarding the chronic disease management market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.

Competitive Landscape and Chronic Disease Management Market Share Analysis

The chronic disease management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Europe chronic disease management market.

The major companies dealing in the Europe chronic disease management market report are Koninklijke Philips N.V., WellSky, Health Catalyst, Cognizant, Pegasystems Inc., Epic Systems Corporation, Hinduja Global Solutions Ltd., NXGN Management, LLC, Casenet, LLC, ExlServings Holdings, Inc., ScienceSoft USA Corporation, Allscripts Healthcare, LLC., Infosys Limited,  IBM corporation, and IBM Corporation among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the chronic disease management market.

For instance,

  • In April 2021, IBM Corporation launches advanced storage solutions designed to simplify data accessibility and availability across hybrid clouds. This new solution launch by parent organization IBM Corporation has enhanced the company’s overall revenue for market.

A colaboração, o lançamento de produtos, a expansão de negócios, a atribuição de prémios e reconhecimento, as joint ventures e outras estratégias dos players do mercado estão a melhorar a pegada da empresa no mercado de gestão de doenças crónicas, o que também proporciona o benefício para o crescimento do lucro da organização .

SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

Sample Image Click on image to enlarge
  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE chronic disease management market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET END USER COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
  5. Europe chronic disease management market: regulations
    1. Regulation in the United States:
    2. Governing Regulations:
    3. CPT Codes:
    4. Practitioner Eligibility:
    5. Patient Eligibility:
    6. Requirements:
    7. Regulations in Europe:
    8. National Strategy and Lead Organizations for Healthcare services in Europe:
    9. Data Privacy Protection in Europe:
    10. Regulations in India:
    11. Relevant Acts for this framework:
    12. Data Privacy Protection in India:
  6. Market Overview
    1. Drivers
      1. INCREASING PREVALENCE OF chronic diseases
      2. Growing geriatric population
      3. Rising per capita income
      4. ADVANCEMENT IN HEALTHCARE INFRASTRUCTURE AND INITIATIVE ACTIVITIES BY GOVERNMENT ORGANIZATION
    2. Restraints
      1. High cost of Services
      2. Security concerns with cloud-based solutions
    3. OPPORTUNITIES
      1. Surge in novel technological advancements
      2. Rising healthcare expenditure
      3. increased reimbursement policies
      4. rising disease management programs
    4. CHALLENGE
      1. Lack of accessibility
  7. IMPACT OF COVID-19 ON THE Europe Chronic disease management Market
    1. IMPACT ON PRICE
    2. impact on demand
    3. STRATEGIC DECISIONS of Government and MANUFACTURERS
    4. Conclusion
  8. Europe chronic disease management market, By type
    1. overview
    2. solution
    3. services
  9. Europe chronic disease management market, By Solution Type
    1. overview
    2. On Premise Solution
    3. Web Based Solution
    4. Cloud Based Solution
  10. Europe chronic disease management market, By SERVICES Type
    1. overview
    2. Implementation Services
    3. Consulting Services
    4. Education Services
    5. OTHERS
  11. Europe chronic disease management market, By disease indication
    1. overview
    2. cardiovascular diseases (cvd)
    3. diabetes
    4. chronic obstructive pulmonary disorders (copd)
    5. asthma
    6. arthritis
    7. cancer
    8. otherS
  12. Europe chronic disease management market, By end user
    1. overview
    2. healthcare providers
      1. hospitals, physician groups, integrated delivery
      2. diagnostic & imaging centers
      3. ambulatory care centers
      4. home healthcare agencies, nursing homes & assisted living facilities
      5. others
    3. healthcare payers
      1. public payers
      2. private payers
    4. others
  13. Europe Chronic Disease Management Market by region
    1. EUROPE
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Netherlands
      7. Belgium
      8. Switzerland
      9. Russia
      10. Turkey
      11. Rest of Europe
  14. EUROPE CHRONIC DISEASE MANAGEMENT Market: COMPANY landscape
    1. company share analysis: Europe
  15. swot analysis
  16. Company profiles
    1. IBM corporation
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. SERVICE PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. Koninklijke Philips N.V.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. COGNIZANT
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. allscripts healthcare, llc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. SOLUTION PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. ALTRUISTA HEALTH
      1. COMPANY SNAPSHOT
      2. SOLUTION PORTFOLIO
      3. RECENT DEVELOPMENTS
    6. casenet, llc
      1. COMPANY SNAPSHOT
      2. PRODUCT & SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    7. Cedar Gate Technologies
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    8. cliexa, inc.
      1. COMPANY SNAPSHOT
      2. SOLUTION PORTFOLIO
      3. RECENT DEVELOPMENTS
    9. Epic Systems Corporation
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    10. exlservice holdings, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. SERVICE PORTFOLIO
      4. RECENT DEVELOPMENTS
    11. Health Catalyst
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    12. Hinduja Europe Solutions Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. infosys limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. SOLUTION PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. medecision
      1. COMPANY SNAPSHOT
      2. SOLUTION PORTFOLIO
      3. RECENT DEVELOPMENT
    15. MINES & Associates, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    16. NXGN Management, LLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. Pegasystems Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. Sciencesoft usa corporation
      1. COMPANY SNAPSHOT
      2. INDUSTRY PORTFOLIO
      3. RECENT DEVELOPMENTS
    19. tcs healthcare technologies
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    20. vivify health, inc.
      1. COMPANY SNAPSHOT
      2. SOLUTION PORTFOLIO
      3. RECENT DEVELOPMENTS
    21. WellSky
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    22. ZEOMEGA
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
  17. questionnaire
  18. related reports

Lista de Tabela

TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)

TABLE 2 NEW CANCER CASES FOR AGE 85+ IN THE U.S.

TABLE 3 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)

TABLE 4 PRICES OF ESSENTIAL CHRONIC DISEASE MANAGEMENT SOLUTIONS

TABLE 5 Europe chronic disease management market, By type, 2019-2028 (USD million)

TABLE 6 Europe solution IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 7 Europe services IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 8 Europe chronic disease management market, By Solution type, 2019-2028 (USD million)

TABLE 9 Europe On Premise solution IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 10 Europe Web Based Solution IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 11 Europe Cloud Based Solution IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 12 Europe chronic disease management market, By Services type, 2019-2028 (USD million)

TABLE 13 Europe implementation services IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 14 Europe consulting services IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 15 Europe education services IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 16 Europe education services IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 17 Europe chronic disease management market, By disease indication, 2019-2028 (USD million)

TABLE 18 Europe cardiovascular diseases (cvd) IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 19 Europe diabetes IN CHRONIC DISEASE MANAGEMENT MARKET, By region 2019-2028 (USD million)

TABLE 20 Europe chronic obstructive pulmonary disorders (copd) IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 21 Europe asthma IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 22 Europe arthritis IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 23 Europe cancer IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 24 Europe others IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 25 Europe chronic disease management market, By end user, 2019-2028 (USD million)

TABLE 26 Europe healthcare roviders IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 27 Europe healthcare roviders in chronic disease management market, By end user, 2019-2028 (USD million)

TABLE 28 Europe healthcare payers IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 29 Europe healthcare payers in chronic disease management market, By end user, 2019-2028 (USD million)

TABLE 30 Europe others IN CHRONIC DISEASE MANAGEMENT MARKET, By region, 2019-2028 (USD million)

TABLE 31 EUROPE Chronic Disease Management Market, By COUNTRY, 2019-2028 (USD Million)

TABLE 32 Europe Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 33 Europe Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 34 Europe Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 35 Europe Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 36 Europe Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 37 Europe Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 38 Europe Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 39 Germany Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 40 Germany Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 41 Germany Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 42 Germany Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 43 Germany Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 44 Germany Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 45 Germany Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 46 U.K. Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 47 U.K. Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 48 U.K. Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 49 U.K. Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 50 U.K. Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 51 U.K. Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 52 U.K. Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 53 France Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 54 France Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 55 France Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 56 France Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 57 France Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 58 France Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 59 France Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 60 Italy Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 61 Italy Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 62 Italy Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 63 Italy Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 64 Italy Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 65 Italy Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 66 Italy Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 67 Spain Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 68 Spain Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 69 Spain Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 70 Spain Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 71 Spain Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 72 Spain Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 73 Spain Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 74 Netherlands Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 75 Netherlands Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 76 Netherlands Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 77 Netherlands Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 78 Netherlands Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 79 Netherlands Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 80 Netherlands Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 81 Belgium Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 82 Belgium Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 83 Belgium Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 84 Belgium Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 85 Belgium Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 86 Belgium Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 87 Belgium Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 88 Switzerland Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 89 Switzerland Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 90 Switzerland Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 91 Switzerland Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 92 Switzerland Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 93 Switzerland Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 94 Switzerland Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 95 Russia Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 96 Russia Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 97 Russia Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 98 Russia Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 99 Russia Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 100 Russia Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 101 Russia Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 102 Turkey Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

TABLE 103 Turkey Solution in Chronic Disease Management Market, By SOLUTION Type, 2019-2028 (USD Million)

TABLE 104 Turkey Services in Chronic Disease Management Market, By SERVICE Type, 2019-2028 (USD Million)

TABLE 105 Turkey Chronic Disease Management Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 106 Turkey Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 107 Turkey Healthcare Providers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 108 Turkey Healthcare Payers in Chronic Disease Management Market, By End User, 2019-2028 (USD Million)

TABLE 109 Rest of Europe Chronic Disease Management Market, By Type, 2019-2028 (USD Million)

Lista de Figura

FIGURE 1 Europe CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION

FIGURE 2 EUROPE CHRONIC DISEASE MANAGEMENT MARKET: DATA TRIANGULATION

FIGURE 3 Europe Chronic disease management market: DROC ANALYSIS

FIGURE 4 Europe Chronic disease management market: Europe VS REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Chronic disease management market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Chronic disease management market: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Chronic disease management market: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE CHRONIC DISEASE MANAGEMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE CHRONIC DISEASE MANAGEMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE chronic disease management market: MARKET END USER COVERAGE GRID

FIGURE 11 Europe Chronic disease management market: SEGMENTATION

FIGURE 12 growing geriatric population is expected to DRIVe THE Europe Chronic disease management market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 SOLUTION SEGMENT is expected to account for the largest share of the Europe CHRONIC DISEASE MANAGEMENT MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF Europe chronic disease management market

FIGURE 15 prevalence of chronic diseases

FIGURE 16 AGING POPULATION In the world (in millions)

FIGURE 17 North AMERICA AGING POPULATION (In millionS)

FIGURE 18 Europe AGING POPULATION (In millionS)

FIGURE 19 Asia-pacific AGING POPULATION (In millionS)

FIGURE 20 Europe chronic disease management market: By type, 2020

FIGURE 21 Europe chronic disease management market: By type, 2019-2028 (USD million)

FIGURE 22 Europe chronic disease management market: By type, CAGR (2021-2028)

FIGURE 23 Europe chronic disease management market: By type, LIFELINE CURVE

FIGURE 24 Europe chronic disease management market: By Solution type, 2020

FIGURE 25 Europe chronic disease management market: By Solution type, 2019-2028 (USD million)

FIGURE 26 Europe chronic disease management market: By Solution type, CAGR (2021-2028)

FIGURE 27 Europe chronic disease management market: By Solution type, LIFELINE CURVE

FIGURE 28 Europe chronic disease management market: By Services type, 2020

FIGURE 29 Europe chronic disease management market: By Services type, 2019-2028 (USD million)

FIGURE 30 Europe chronic disease management market: By Services type, CAGR (2021-2028)

FIGURE 31 Europe chronic disease management market: By Services type, LIFELINE CURVE

FIGURE 32 Europe chronic disease management market: By disease indication, 2020

FIGURE 33 Europe chronic disease management market: By disease indication, 2019-2028 (USD million)

FIGURE 34 Europe chronic disease management market: By disease indication, CAGR (2021-2028)

FIGURE 35 Europe chronic disease management market: By disease indication, LIFELINE CURVE

FIGURE 36 Europe chronic disease management market: By end user, 2020

FIGURE 37 Europe chronic disease management market: By end user, 2019-2028 (USD million)

FIGURE 38 Europe chronic disease management market: By end user, CAGR (2021-2028)

FIGURE 39 Europe chronic disease management market: By end user, LIFELINE CURVE

FIGURE 40 EUROPE Chronic Disease Management MARKET: SNAPSHOT (2020)

FIGURE 41 EUROPE Chronic Disease Management MARKET: BY COUNTRY (2020)

FIGURE 42 EUROPE Chronic Disease Management MARKET: BY COUNTRY (2021 & 2028)

FIGURE 43 EUROPE Chronic Disease Management MARKET: BY COUNTRY (2020 & 2028)

FIGURE 44 EUROPE Chronic Disease Management MARKET: BY TYPE (2021-2028)

FIGURE 45 Europe Chronic Disease Management market: company share 2020 (%)

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Navegue pelas páginas relacionadas

Banner